Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study (Q33409117)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study |
scientific article |
Statements
1 reference
Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study (English)
1 reference
Jacques Grill
1 reference
Danuta Perek
1 reference
Birgit Geoerger
1 reference
Isabelle Aerts
1 reference
Lyle Gesner
1 reference
Luis Madero
1 reference
Josep Sanchez de Toledo Codina
1 reference
Joris Verlooy
1 reference
Edward Estlin
1 reference
Laura Cisar
1 reference
Aurora Breazna
1 reference
Andrew Dorman
1 reference
Simon Bailey
1 reference
Gary Nicolin
1 reference
Richard G Grundy
1 reference
European Consortium Innovative Therapies for Children with Cancer (ITCC) and the European Society for Paediatric Oncology (SIOPE) brain tumor group
1 reference
14 July 2013
1 reference
1 reference
15
1 reference
1236-1243
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference